CRISPR/Cas9 Genome Editing for Tissue-Specific In Vivo Targeting: Nanomaterials and Translational Perspective

Abstract

Adv. Sci. 2023, 10, 2207512 DOI: 10.1002/advs.202207512 In the original published article, Satoru Kawakita and Shahid Khan affiliations are swapped. Please find below the correct affiliations. D. K. Sahel Department of Pharmacy Birla Institute of Technology and Science-Pilani BITS-Pilani, Vidya Vihar, Pilani, Rajasthan 333031, India L. K. Vora, D. Mishra, R. R. Singh Thakur School of Pharmacy Queen's University Belfast 97 Lisburn Road, Belfast BT9 7BL, UK E-mail: L.Vora@qub.ac.uk A. Saraswat, K. Patel College of Pharmacy & Health Sciences St. John's University Queens, NY11439, USA S. Sharma, S. Kawakita Terasaki Institute for Biomedical Innovation Los Angeles, CA 90064, USA J. Monpara Department of Pharmaceutical Sciences University of Sciences Philadelphia, PA 19104, USA A. A. D'Souza Graduate School of Pharmaceutical Sciences and School of Pharmacy Duquesne University Pittsburgh, PA 15282, USA K. P. Tryphena, D. K. Khatri Molecular and Cellular Neuroscience Lab Department of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad Telangana 500037, India E-mail: dharmendra.niperhyd@nic.in S. Khan Department of Biomedical Engineering University of California Davis, CA 95616, USA M. Azhar Research and Development Tata Medical and Diagnostics Limited Mumbai, Maharashtra 400001, India.